{
  "id": "63ee5eeaf36125a426000002",
  "type": "yesno",
  "question": "Does mutation of ARTEMIS gene causes severe combined immunodeficiency?",
  "ideal_answer": "Artemis mutation disrupts development of adaptive immunity and leads to severe combined immunodeficiency.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/36385359",
    "http://www.ncbi.nlm.nih.gov/pubmed/35801871",
    "http://www.ncbi.nlm.nih.gov/pubmed/35773051",
    "http://www.ncbi.nlm.nih.gov/pubmed/35729475"
  ],
  "snippets": [
    {
      "text": "RESULTS: Seven infants were diagnosed with SCID, yielding an incidence of 1 in 22,819 live births. Four of these infants had Artemis-type SCID.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35729475",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Artemis deficiency disrupts development of adaptive immunity and leads to radiosensitive T- B- severe combined immunodeficiency (RS-SCID).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35801871",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Encouraging data for X-SCID and preclinical work for Artemis-SCID and RAG1-SCID are paving the way for the therapy to become a viable curative treatment option.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35773051",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Pathogenic variants in DCLRE1C encoding Artemis cause T-B-NK+ severe combined immunodeficiency (SCID), and patients with Artemis-deficient SCID (ART-SCID) require definitive therapy with allogeneic hematopoietic cell transplantation (HCT).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36385359",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}